Announcements Trials
Browse Landscape

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Breast 5Gynecologic 2Gastrointestinal 2Thoracic 1Head & Neck 1Genitourinary 1Endocrine 1Classical hematology 1CNS 1

Conditions

Pancreatic Neoplasms 2Fanconi Anemia, Complementation Group D1 1Breast Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Genotype × Gastrointestinal × Clear all
NCT05329597 2022-04-15

Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown
88 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Memorial Sloan Kettering Cancer Center

Withdrawn
BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡